Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Carbidopa Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | THPO | P40225 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 4/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | APEX1 | P27695 | 2/20 | 0.65 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.65 |
| ▸ | USP2 | O75604 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbidopa Anhydrous SCHEMBL29392554 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL2688295 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL8407333 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL5051647 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL30803536 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL1211698 | 0.98 | KDM4E (0.97) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL1217887 | 0.98 | HSD17B10 (0.97) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL29658622 | 0.98 | HSD17B10 (0.97) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL9064019 | 0.98 | HSD17B10 (0.97) | HSD17B10KDM4EMAPTTDP1HPGD | |
| Carbidopa Anhydrous SCHEMBL19475325 | 0.98 | HSD17B10 (0.97) | HSD17B10KDM4EMAPTTDP1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 29223 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4389173-B1 | DEVICE FOR SUBCUTANEOUS DELIVERY OF FLUID MEDICAMENT | NEURODERM LTD (IL) | 2026-05-27 | — | — | EP | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| WO-2026106939-A1 | IMPROVING SYMPTOMS IN MID- TO LATE-STAGE PARKINSON'S DISEASE PATIENTS USING WITH DEEP BRAIN STIMULATION | VANDERBILT UNIVERSITY (US) | 2026-05-21 | — | — | WO | claimed |
| EP-3782614-B1 | MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF | IMPAX LABORATORIES LLC (US) | 2026-05-20 | — | — | EP | claimed |
| WO-2026102000-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS RELATED TO GLUCOSYLCERAMIDASE BETA 1 DEFICIENCY | VOYAGER THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026099869-A1 | DIGITAL THERAPEUTICS AND COMBINATION THERAPY FOR THE TREATMENT OF PARKINSON'S DISEASE | REMEPY HEALTH LTD (IL) | 2026-05-15 | — | — | WO | claimed |
| US-20260130880-A1 | DIGITAL THERAPEUTICS AND COMBINATION THERAPY FOR THE TREATMENT OF PARKINSONS DISEASE | REMEPY HEALTH LTD (IL) | 2026-05-14 | — | — | US | claimed |
| US-20260131140-A1 | MODIFYING EARLY-STAGE PARKINSON'S DISEASE PROGRESSION WITH DEEP BRAIN STIMULATION | VANDERBILT UNIV (US) | 2026-05-14 | — | — | US | claimed |
| US-20260130881-A1 | SUSTAINED RELEASE DEVICE CONTENTS FOR TREATMENT OF PARKINSON'S DISEASE AND OTHER DISORDERS | BUSHARA KHALAFALLA (US) | 2026-05-14 | — | — | US | claimed |
| EP-4740962-A1 | PHARMACEUTICAL COMPOSITION, FORMULATION CONTAINING PHARMACEUTICAL COMPOSITION, KIT CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION METHOD FOR PHARMACEUTICAL COMPOSITION, AND USE OF PHARMACEUTICAL COMPOSITION | Shanghai WD Pharmaceutical Co., Ltd (CN) | 2026-05-13 | — | — | EP | claimed |
| US-4421767-A | 3-(HYDROXYPHENYL)-2-AMINO-3-BUTENOIC ACID OR DERIVATIVE | MERRELL TORAUDE ET COMPAGNIE (FR) | 1983-12-20 | — | — | US | claimed |
| US-4413012-A | Method for treating depression | MERRELL TORAUDE ET COMPAGNIE (FR) | 1983-11-01 | — | — | US | claimed |
| EP-0083032-A2 | Rectally administrable suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1983-07-06 | — | — | EP | claimed |
| US-4389415-A | ALPHA-METHYL-P-TYROSINE, HYDRAZINO PHENYLPROPIONIC ACID | MERCK & CO., INC. (US) | 1983-06-21 | — | — | US | claimed |
| EP-0066518-A2 | Compounds and methods for treating depression | MERRELL DOW FRANCE ET CIE (FR) | 1982-12-08 | — | — | EP | claimed |
| EP-0051278-A1 | Soft tertiary amine esters of bio-affecting carboxylic acids, processes for preparing and a pharmaceutical composition containing the same | MERCK & CO. INC. (US) | 1982-05-12 | — | — | EP | claimed |
| US-4329356-A | Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane | ELI LILLY AND COMPANY (US) | 1982-05-11 | — | — | US | claimed |
| US-4313956-A | Novel sypathomimetic amine prodrugs | INTERX RESEARCH CORP. (US) | 1982-02-02 | — | — | US | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |